Please assess the completion status of the following clinical trial:

Trial Title: Adaptive Physical Activity for Chronic Stroke

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* evidence of stroke (ischemic or hemorrhagic) minimum 6 months prior in men or women ages 40 or older;~* residual hemiparetic gait deficits;~* already completed all conventional inpatient and outpatient physical therapy;~* ability to rise from a chair unaided and without an assistive device~Exclusion Criteria:~* cardiac history of active unstable angina, recent (less than 3 months) myocardial infarction, or congestive heart failure (NYHA category II or higher);~* orthopedic, circulatory, or chronic pain conditions restricting exercise;~* active cancer; poorly controlled hypertension ( greater than 180/100 on 2 readings separated by 5 minutes rest);~* dementia;~* severe receptive or global aphasia with inability to follow 2-step commands;~* co-morbid non-stroke neurological disorder that impairs mobility (e.g. multiple sclerosis or Parkinson's);~* untreated clinical depression;~* inability to complete the 6-Minute Walk test during baseline testing

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- APA-Stroke (Type: EXPERIMENTAL): The APA-stroke exercise program designed specifically for individuals with hemiparetic gait deficits due to stroke. These progressive exercises focus on walking, balance and weight shifting and include an exercise homework component.
- Sittercise (Type: ACTIVE_COMPARATOR): Sittercise is not stroke specific. This less vigorous exercise program consists of seated exercise, focusing on stretching to improve general range of motion and weight exercises to strengthen the trunk, arms, and legs. There is no assigned exercise homework associated with this group.

Based on this trial design, predict the completion outcome and termination type (if applicable).